header 3
Login
Ouch Signup
e-mail address:

Title:

First Name:

Last Name:

Untitled:


http://www.healthmatchbc.org/
Home Clinical Clinical News NCRC awards €5m for paediatric research

NCRC awards €5m for paediatric research

A new €5 million research partnership between Trinity College Dublin and the National Children’s Research Centre (NCRC) hopes to eventually develop more targeted treatments for children’s inflammatory diseases such as eczema, asthma, childhood rheumatic diseases and cystic fibrosis.

According to Professor Carlos Blanco, Director of Research at the NCRC, the partnership, announced last week, will target world class research on the early origin of disease. “Through research we will drive improvement in the care and treatment of children. This is a very exciting development in Irish paediatric research and brings together a critical mass in paediatric immunology which will allow for the translation of leading research into real tangible clinical benefits in patient care for children,” said Prof Blanco.  Professor Padraic Fallon, SFI Stokes Professor of Translational Immunology at the TCD School of Medicine, has been appointed as Director of the new Paediatric Research in Translational Immunology Programme. He will be joined by Professor Alan Irvine, consultant dermatologist at Our Lady’s Children’s Hospital, Crumlin, as Associate Director.  Researchers at TCD, meanwhile, in collaboration with NUI Galway’s School of Psychology and Centre for Pain Research, are attempting to establish the economic costs of chronic pain in Ireland, as part of the Health Research Board (HRB) and HSE-funded PRIME Study (Prevalence, Impact and Cost of Chronic Non-Cancer Pain in Ireland). The researchers carried out in-depth interviews with 140 chronic pain patients to find out about direct costs such as medical treatments and indirect costs such as lost work productivity.  Research psychologist at NUI Galway Dr Miriam Raftery said: “We found that the average cost per chronic pain patient was €5,665 per year across all grades of pain severity. “However, the annual costs increased according to the severity of pain, rising to €10,454 per patient for those with the highest level of pain and disability.” A relatively small proportion of patients with the most severe level of pain accounted for a disproportionately large portion of the costs, they found.  Inpatient hospital treatment accounted for the highest proportion of overall costs.

 

Add comment



Refresh

Favorite Pages
Please login first to manage your favorite pages.
IMN Poll
Is it OK to increase taxes in order to provide universal healthcare?